The life sciences industry is rapidly reinventing itself for its digital-first world. Remote engagement was the first of many strategic changes needed to better engage with HCPs in the new normal. Pharma, biotech and med-device organizations will need to look beyond a single channel of change to provide more value to HCPs. Collaboration across medical and commercial teams will be crucial to leading the pack.
This whitepaper explores the survey findings of 1,000+ life sciences professionals from both commercial and medical teams who are in the midst of shaping new strategies and tactics of reinvention for the digital age. In this report you will learn about:
- Collaboration opportunities and challenges between Medical Affairs and the Commercial Sales teams
- Digital priorities and investment areas for Medical Affairs in 2021
- Demand for digital engagement amongst customers and trends for the future
- Opportunities that lie in increased collaboration between medical and commercial teams
More valuable content for customers
Responding to changing needs of HCP’s
Increase in personalized engagement
Get insights from over 1000 life sciences executives about the role MSLs play in today’s digital-first era. Get your exclusive access to the survey report.